SCHEMBL12037274

SCHEMBL12037274

c1ccc2c(c1)cc(-c1ccc3oc4ccc(-c5ccc6ccc(-c7cc8c9ccccc9ccc8c8ccccc78)cc6c5)cc4c3c1)c1ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.42
▸ ALDH1A1 P00352 7/20 0.42
▸ MAPT P10636 5/20 0.42
▸ HPGD P15428 3/20 0.42
▸ TSHR P16473 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ GLA P06280 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ HNF4A P41235 1/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12037293 0.97 KDM4E (0.44) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL12037411 0.97 KDM4E (0.44) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL12037332 0.97 GPR84 (0.41) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL12037283 0.96 KDM4E (0.43) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL12037276 0.96 KDM4E (0.43) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL12037282 0.94 KDM4E (0.44) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL12024522 0.94 GPR84 (0.43) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL12024488 0.94 GPR84 (0.43) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL12037258 0.94 GPR84 (0.43) KDM4EALDH1A1MAPTHPGDTSHR
SCHEMBL12037285 0.93 KDM4E (0.47) KDM4EALDH1A1MAPTHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940412-B2 Material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-01-27 — — US disclosed
US-8940412-B2 Material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-01-27 — — US disclosed
US-20110315965-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2011-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110315965-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT LEF1, TERF2, BPTF KDM4E 1891/4885ALDH1A1 1640/4885MAPT 196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback